NorthRock Partners’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
Other funds holding IHI
AAS
NorthRock Partners's IHI Position: Q2 2026 in Review
NorthRock Partners reduced its iShares US Medical Devices ETF (IHI) stake by 15% in Q2 2026, selling an estimated $88.6K and leaving 9,753 shares worth $482K. The position accounts for 0.01% of the portfolio, ranked #445.
NorthRock Partners first reported a position in IHI in Q3 2019 and has held it in 28 quarters since. The position peaked at $839K in Q4 2021. 501 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- NorthRock Partners held 9,753 shares of iShares US Medical Devices ETF worth $482K as of Q2 2026.
- NorthRock Partners sold 1,746 iShares US Medical Devices ETF shares in Q2 2026, an estimated $88.6K.
- iShares US Medical Devices ETF made up 0.01% of NorthRock Partners's portfolio in Q2 2026, its #445 holding.
- NorthRock Partners first reported a position in iShares US Medical Devices ETF in Q3 2019 and has held it in 28 quarters since.
- NorthRock Partners's iShares US Medical Devices ETF position peaked at $839K in Q4 2021.
- 501 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on NorthRock Partners's 13F filing for Q2 2026, filed 11 Aug 2026.